Stocks and Investing Stocks and Investing
Mon, November 7, 2022
[ 12:00 AM ] - WOPRAI
Courtney Yakavonis Maintained (WSC) at Buy with Increased Target to $56 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Ben Isaacson Downgraded (WLK) to Sell on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
David Begleiter Maintained (WLK) at Hold with Increased Target to $105 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Arun Viswanathan Maintained (WLK) at Buy with Increased Target to $113 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Neel Kumar Maintained (WLK) at Hold with Decreased Target to $110 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Joshua Pokrzywinski Maintained (WMS) at Buy with Decreased Target to $120 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
John Difucci Upgraded (WDAY) to Hold on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Kutgun Maral Maintained (WBD) at Buy with Decreased Target to $27 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Patrick Tyler Brown Maintained (WCN) at Strong Buy with Increased Target to $157 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Adrienne Yih Maintained (W) at Sell with Decreased Target to $34 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Steven Shemesh Maintained (W) at Hold with Decreased Target to $35 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Stephen Trent Maintained (AAL) at Hold with Decreased Target to $16 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Sheila Kahyaoglu Maintained (AAL) at Hold and Held Target at $15 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Kevin Kumar Maintained (APPN) at Strong Buy with Decreased Target to $55 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Joe Meares Maintained (APPN) at Strong Buy with Decreased Target to $50 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Ramsey El-Assal Maintained (ARBK) at Hold with Decreased Target to $1 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Tim Long Maintained (AAPL) at Hold with Decreased Target to $144 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Wamsi Mohan Maintained (AAPL) at Hold with Decreased Target to $154 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Nick Cheng Upgraded (ACMR) to Hold and Decreased Target to $7 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Joseph Spak Downgraded (ADNT) to Hold and Held Target at $36 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Colin Langan Maintained (ADNT) at Buy with Increased Target to $42 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
Tejas Savant Maintained (ADPT) at Hold with Decreased Target to $16 on, Nov 7th, 2022
[ 12:00 AM ] - WOPRAI
James Thalacker Maintained (AEE) at Buy with Increased Target to $90 on, Nov 7th, 2022
Fri, November 4, 2022
[ 12:00 AM ] - WOPRAI
Mark Devries Maintained (AER) at Buy with Increased Target to $66 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Atif Malik Upgraded (AEIS) to Strong Buy and Decreased Target to $95 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Quinn Bolton Maintained (ACMR) at Strong Buy with Decreased Target to $10 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Quinn Bolton Maintained (ACLS) at Strong Buy with Increased Target to $77 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Connor Lynagh Initiated (ACDC) at Buy and Held Target at $30 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Salveen Richter Downgraded (ACAD) to Strong Sell and Decreased Target to $12 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
James Molloy Maintained (AQST) at Strong Buy with Decreased Target to $7 on, Nov 4th, 2022

James Molloy Maintained (AQST) at Strong Buy with Decreased Target to $7 on, Nov 4th, 2022


Published on 2024-10-27 23:57:46 - WOPRAI, James Molloy
  Print publication without navigation


James Molloy of Alliance Global Partners, Maintained "Aquestive Therapeutics, Inc." (AQST) at Strong Buy with Decreased Target from $10 to $7 on, Nov 4th, 2022.

James has made no other calls on AQST in the last 4 months.



There are 2 other peers that have a rating on AQST. Out of the 2 peers that are also analyzing AQST, 0 agree with James's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with James

  • Francois Brisebois of "Oppenheimer" Initiated at Buy and Held Target at $8.5 on, Wednesday, September 7th, 2022
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $5 on, Tuesday, September 6th, 2022
Contributing Sources